Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

Agency Leadership

Complete Response Letters

Drug Review Profiles

Reimbursement Dispute Between Novitas And iRhythm Hits An Impasse

Apr 13 2021

• By Reed Miller

Two business teams and money between them. Tender and financial competition concept. Fight for financing. Money sharing. Distribution of funds. - Image ID: 2C4Y628 — • Source: Alamy

Related Content

Updated: Reimbursement Questions Jeopardize Hillrom/Bardy Merger

Mar 04 2021

Reimbursement For Long-Term Cardiac Monitoring Remains Uncertain, iRhythm Reports

Mar 01 2021

Boston Scientific Bets Big On Monitoring; Buys Preventice For Up To $1.25Bn

Jan 22 2021

Related Companies

iRhythm Technologies, Inc.

BioTelemetry, Inc.

Bardy Diagnostics, Inc.

Cardiac Insight, Inc.

Preventice Solutions, Inc.

Philips Healthcare

Boston Scientific Corporation

Hill-Rom Services Inc.

Additional Topics

Reimbursement Digital Health Commercial Companies Business Strategies Cardiovascular Cardiology Medical Device

More from Policy & Regulation

More from Medtech Insight

Twitter feed RSS feed RSS feed

About

About UsOpens in new window
Meet the Team
Editorial Standards
Award-Winning Journalism
AdvertiseOpens in new window
Contact Us

Account

My Account
My View
Email Preferences
Start Free TrialOpens in new window

More

Medtech Top 100 Ranking
Data Trackers
FDA Warning Letters

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window